BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26754737)

  • 1. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.
    Alasfar S; Carter-Monroe N; Rosenberg AZ; Montgomery RA; Alachkar N
    BMC Nephrol; 2016 Jan; 17():7. PubMed ID: 26754737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
    Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
    J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Lorenz EC; Sethi S; Leung N; Dispenzieri A; Fervenza FC; Cosio FG
    Kidney Int; 2010 Apr; 77(8):721-8. PubMed ID: 20130531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
    Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
    BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis.
    Angelo JR; Bell CS; Braun MC
    Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
    Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
    Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Survival.
    de Paula LC; Mazzali M; de Sousa MV
    Ann Transplant; 2023 Jul; 28():e940502. PubMed ID: 37461201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Glomerulonephritis in Renal Transplantation: Experience in Our Renal Transplantation Center.
    Cañas L; López D; Pérez JF; Bancu I; Juega J; Ariza A; Bonet J; Lauzurica R
    Transplant Proc; 2015 Oct; 47(8):2354-6. PubMed ID: 26518925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation.
    Caravaca-Fontán F; Polanco N; Villacorta B; Buxeda A; Coca A; Ávila A; Martínez-Gallardo R; Galeano C; Valero R; Ramos N; Allende N; Cruzado-Vega L; Pérez-Sáez MJ; Sevillano Á; González E; Hernández A; Rodrigo E; Fernández-Ruiz M; Aguado JM; Pérez Valdivia MÁ; Pascuall J; Andrés A; Praga M;
    Nephrol Dial Transplant; 2023 Jan; 38(1):222-235. PubMed ID: 35404425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
    Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC
    Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series.
    Dalvin LA; Fervenza FC; Sethi S; Pulido JS
    Ophthalmology; 2016 Jul; 123(7):1588-94. PubMed ID: 26996341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
    Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival.
    Andresdottir MB; Assmann KJ; Hoitsma AJ; Koene RA; Wetzels JF
    Transplantation; 1997 Jun; 63(11):1628-33. PubMed ID: 9197358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of the classification system for membranoproliferative glomerulonephritis.
    Lu Y; Shen P; Li X; Xu Y; Pan X; Wang W; Chen X; Zhang W; Ren H; Chen N
    Contrib Nephrol; 2013; 181():175-84. PubMed ID: 23689579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular disease recurrence in second and subsequent kidney transplants.
    Kennedy C; Obilana A; O'Brien F; O'Kelly P; Dorman A; Denton M; Magee C; Conlon P
    Clin Nephrol; 2013 Jan; 79(1):31-6. PubMed ID: 23073068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
    Sethi S; Fervenza FC
    Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.
    Nakano M; Karasawa K; Moriyama T; Uchida K; Nitta K
    Clin Exp Nephrol; 2019 Jun; 23(6):852-858. PubMed ID: 30854618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
    Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.